Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    "mandibuloacral dysplasia" [DISEASE] OR NCT00025883 [ID-NUMBER] OR NCT00715546 [ID-NUMBER] OR NCT00677313 [ID-NUMBER] OR NCT00457938 [ID-NUMBER]
Show Display Options
Download search resultsDownload the search results for:
"mandibuloacral dysplasia" [DISEASE] OR NCT00025883 [ID-NUMBER] OR NCT00715546 [ID-NUMBER] OR NCT00677313 [ID-NUMBER] OR NCT00457938 [ID-NUMBER] (4 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy
Condition: Lipodystrophy
Intervention: Procedure: autologous transplantation of liposuction material enriched with adipose-derived stem cells
2 Active, not recruiting Leptin to Treat Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: Metreleptin
3 Recruiting Novel Therapies for Metabolic Complications of Lipodystrophies
Conditions: Insulin Resistance;   Hypertriglyceridemia;   Diabetes;   Hepatic Steatosis
Interventions: Other: low-fat diet  ( Still recruiting );   Other: Diet
4 Active, not recruiting An Open-Label Treatment Protocol to Provide Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With Lipodystrophy
Condition: Lipodystrophy
Intervention: Drug: metreleptin

Indicates status has not been verified in more than two years